Quest Diagnostics Incorporated
DGX
$178.03
-$0.81-0.45%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.18% | 15.19% | 12.09% | 14.55% | 8.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.18% | 15.19% | 12.09% | 14.55% | 8.41% |
| Cost of Revenue | 11.54% | 14.35% | 12.71% | 13.37% | 8.64% |
| Gross Profit | 16.54% | 16.83% | 10.84% | 17.03% | 7.94% |
| SG&A Expenses | 13.66% | 18.23% | 6.19% | 12.78% | 15.20% |
| Depreciation & Amortization | 21.88% | 34.48% | 34.48% | 37.04% | 18.52% |
| Other Operating Expenses | 200.00% | 100.00% | 0.00% | 300.00% | -200.00% |
| Total Operating Expenses | 12.22% | 15.46% | 11.63% | 13.73% | 9.94% |
| Operating Income | 18.98% | 13.71% | 15.00% | 19.87% | 0.00% |
| Income Before Tax | 11.26% | 25.16% | 7.30% | 24.08% | -0.98% |
| Income Tax Expenses | 18.46% | 31.08% | -10.61% | 70.00% | -4.41% |
| Earnings from Continuing Operations | 9.28% | 23.33% | 12.98% | 15.12% | 0.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -27.27% | -27.27% | -7.14% | -7.69% | 8.33% |
| Net Income | 8.41% | 23.14% | 13.40% | 15.63% | 0.44% |
| EBIT | 18.98% | 13.71% | 15.00% | 19.87% | 0.00% |
| EBITDA | 17.57% | 15.75% | 16.51% | 20.91% | 3.02% |
| EPS Basic | 8.00% | 22.14% | 13.48% | 15.62% | 0.89% |
| Normalized Basic EPS | 16.09% | 12.46% | 7.51% | 10.22% | 0.88% |
| EPS Diluted | 8.54% | 21.67% | 12.79% | 20.21% | 1.53% |
| Normalized Diluted EPS | 16.10% | 12.46% | 6.56% | 9.23% | 1.77% |
| Average Basic Shares Outstanding | 0.00% | 0.90% | 0.00% | -0.89% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.89% | 0.89% | 0.00% | -0.88% |
| Dividend Per Share | 6.67% | 6.67% | 6.67% | 5.63% | 5.63% |
| Payout Ratio | -0.02% | -0.13% | -0.06% | -0.09% | 0.05% |